NEW YORK (GenomeWeb) –WuXi AppTec subsidiary WuXi NextCode said today that its sequencing facility in Shanghai, China has been accredited by the College of American Pathologists.

The company also said that the Shanghai lab is the first such lab in China to be licensed by the State of California, allowing the company to process samples from the state. WuXi NextCode is also the only sequencing facility in China with CLIA certification from the US Centers for Medicare and Medicaid, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Hopkins' Geoffrey Ling discusses the promise of genomic vaccines at Scientific American.

In Nature this week: mitochondrial genome of extinct South American ungulate, and more.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

Jul
20
Sponsored by
NuGEN

This webinar describes the characterization of gene fusions across distinct subtypes of melanoma.